Omri Drory

Director Ejecutivo en Renewal Bio Ltd. .

Finance

Health Technology

Perfil

Omri Drory is the founder of Renewal Bio Ltd., a company founded in 2022 where he currently holds the title of Interim Chief Executive Officer.
He is also currently working as a General Partner at NFX Capital Management LLC since 2020.

Cargos activos de Omri Drory

Empresas	Cargo	Inicio
NFX Capital Management LLC NFX Capital Management LLC Investment ManagersFinance NFX Capital Management LLC (NFX Capital) is a venture capital firm founded in 2015. The firm is headquartered in San Francisco, California.	Inversor de Capital Privado	01/12/2020
Renewal Bio Ltd. Renewal Bio Ltd. BiotechnologyHealth Technology Renewal Bio Ltd. is an Israeli company that focuses on renewing human health. The company is based in Tel Aviv, Israel. The company has published several articles on topics such as ex utero mouse embryogenesis and post-gastrulation synthetic embryos. The company's goal is to create complete human day 14 post-implantation embryo models. It was founded in 2022 by Jacob Hanna and Omri Drory, with Omri Drory serving as the CEO since then.	Director Ejecutivo	02/06/2022

Todos los cargos activos de Omri Drory

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Omri Drory.

Relaciones

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas privadas	2
NFX Capital Management LLC NFX Capital Management LLC Investment ManagersFinance NFX Capital Management LLC (NFX Capital) is a venture capital firm founded in 2015. The firm is headquartered in San Francisco, California.	Finance
Renewal Bio Ltd. Renewal Bio Ltd. BiotechnologyHealth Technology Renewal Bio Ltd. is an Israeli company that focuses on renewing human health. The company is based in Tel Aviv, Israel. The company has published several articles on topics such as ex utero mouse embryogenesis and post-gastrulation synthetic embryos. The company's goal is to create complete human day 14 post-implantation embryo models. It was founded in 2022 by Jacob Hanna and Omri Drory, with Omri Drory serving as the CEO since then.	Health Technology